At the forefront of immuno-profiling and autoantibody discovery, Protagen's SeroTag® technology identifies biomarkers to overcome challenges in cancer immunotherapies and autoimmune disease treatments. They lead in patient stratification for autoimmune diseases, offering disease-specific NavigAID panels that profile individual patients' conditions and immune status. Their diagnostic tests aid in the detection of autoantibodies, guiding treatment decisions and improving the likelihood of successful outcomes in cancer immunotherapy and autoimmune disease treatment.